-+ 0.00%
-+ 0.00%
-+ 0.00%

TARSUS PHARMACEUTICALS, INC. : BARCLAYS REINSTATES COVERAGE WITH OVERWEIGHT RATING; PRICE TARGET $110

Reuters·09/16/2026 10:22:14

Please log in to view news